GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Question] is 97.9% actually fine or am I being sold a rounding error — 26 comments in the full submission. View in context.
3.8k
c/retatrutide·submitted 5 months ago by u/titration_marshal

[Question] is 97.9% actually fine or am I being sold a rounding error

Questionbranch of 7 comments

is 97.9% actually fine or am I being sold a rounding error. I will put the method line and the batch identifier up front because that is what makes this checkable. 97.9%. Those are measured, not estimated, and not rounded up in my favour. It is a triple agonist at the GLP-1, GIP and glucagon receptors. The glucagon…

Read the full submission and all 26 comments →

This branch

7 comments, started 5 months ago
u/incretin_ivyMOD394 points·5 months ago

Removed the escalation schedule. There is no published protocol for members to follow and inventing one here is exactly what this board does not do.

replysharereportpermalink
u/ewan_zielinski302 points·4 months ago

Nothing containing this compound is approved anywhere. Research-use-only material is not approved for human use, and that is a statement of fact rather than a disclaimer.

replysharereportpermalink
u/deleted_my_history93 points·4 months ago

small trial, big effect, wide error bars

replysharereportpermalink
u/devils_advocate_d237 points·4 months ago

Watched heart rate on a wearable across twelve weeks because the threads said to. It moved a little and I have no idea whether that means anything.

replysharereportpermalink
u/blunt_coldbox_2024327 points·4 months ago

Independent purity testing on this compound is thin compared with the older molecules, simply because fewer members have paid for it. Fewer results means wider uncertainty, not a verdict.

replysharereportpermalink
u/freya_baptista95 points·4 months ago

the escalation is where most of the reported trouble sits

replysharereportpermalink
u/divya_bakken43 points·4 months ago·edited

the energy-expenditure story is mechanistically interesting and clinically unproven

replysharereportpermalink

← back to the whole thread

About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.com
Sponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.